Cathay Biotech Stock Hits Day Low of CNY 50.08 Amid Price Pressure

Cathay Biotech, Inc., a prominent player in the specialty chemicals sector, experienced a notable decline of 4.7% on October 14, 2025. The stock reached an intraday low of CNY 50.08, reflecting a challenging trading day for the company. Over the past week, Cathay Biotech has seen a decrease of 3.69%, while its performance over the past month has dropped by 7.43%.
Despite these short-term fluctuations, the company has reported positive results for the last four consecutive quarters, indicating a degree of operational stability. The firm boasts a robust cash position, with cash and equivalents totaling CNY 20,620.69 million. Additionally, the company has a low interest coverage ratio, suggesting minimal interest costs.

In terms of valuation, Cathay Biotech has a price-to-book ratio of 1.70 and a return on equity of 3.01%. While the stock has faced challenges over longer time frames, including a 32.97% decline over the past five years, it has shown resilience with a year-to-date performance of 29.18%, outperforming the China Shanghai Composite index.